Gotham Asset Management, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 142 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2019. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
Gotham Asset Management, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2019$68,000
-16.0%
15,842
+13.5%
0.00%0.0%
Q2 2019$81,000
-65.5%
13,952
-67.3%
0.00%
-66.7%
Q2 2016$235,000
-67.1%
42,723
-55.7%
0.00%
-62.5%
Q1 2016$715,000
-21.9%
96,406
-12.5%
0.01%
-20.0%
Q4 2015$915,000
-22.1%
110,163
+1.0%
0.01%
+11.1%
Q1 2015$1,175,000109,0800.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2019
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 15,461,829$2,037,8690.36%
MSD Partners, L.P. 15,151,516$1,996,9700.16%
MSD Partners, L.P. 7,575,758$998,4850.08%
MAGNOLIA CAPITAL ADVISORS LLC 865,938$65,5520.03%
Allred Capital Management, LLC 253,000$33,3450.02%
CHIRON CAPITAL MANAGEMENT, LLC 77,023$10,1520.01%
Boxer Capital, LLC 1,100,000$144,9800.01%
GSA CAPITAL PARTNERS LLP 569,566$750.01%
Sugarloaf Wealth Management, LLC 75,500$9,9510.00%
Owen LaRue, LLC 11,825$1,5590.00%
View complete list of ZIOPHARM ONCOLOGY INC shareholders